Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 266-164-2 | CAS number: 66108-95-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicity to reproduction
Administrative data
- Endpoint:
- one-generation reproductive toxicity
- Remarks:
- based on test type (migrated information)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 06.09.1980-01.12.1980
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: This study was conducted scientifically and in accordance with Good Laboratory Practices.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 981
Materials and methods
Test guideline
- Qualifier:
- no guideline available
- Principles of method if other than guideline:
- Sixty male and 120 sexually mature female rats were used in this study of fertility and general reproduction performance with Iohexol. These rats were approximately 12 weeks of age and had been acclimated in this laboratory for 26 days prior to study initiation. Each rat was assigned a unique number and ear-tagged for identification when placed on study. Prior to mating, all rats were housed individually in suspended wire-mesh cages in a temperature, humidity and light controlled room. All rats were randomly assign according to body weights by a computer-generated program to one control and three treatment groups consisting of 15 males and 30 females each.All females were smeared daily to establish estrous cycles 10 days prior to test article administration and until evidence of copulation was obatined or until the mating period terminated. Following initial treatment of the female rats (every other day for 14 days), one untreated male was housed with two females of the same strain and source in a platic case with gound corn corb bedding for a mating period of 10 days. The occurence of copulation was determined by a vaginal smear for sperm or by daily inspection for a copulatory plug. The day evidence of mating was detected was designated day 0 of gestation and the female was returned to an individual plastic cage. If evidence of copulation was not found during the initial 10 day period, the female was placed with another male from the same treatment group for an additional five days or until evidence of mating was detected. At the end of the second mating period, all animals were separated, at this time the males were returned to individual suspended wire-mesh cages and the females were housed in individual plastic cages with corn cob bedding.
- GLP compliance:
- yes
Test material
- Reference substance name:
- Iohexol
- EC Number:
- 266-164-2
- EC Name:
- Iohexol
- Cas Number:
- 66108-95-0
- Molecular formula:
- C19H26I3N3O9
- IUPAC Name:
- 5-[acetyl(2,3-dihydroxypropyl)amino]-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
Administration / exposure
- Route of administration:
- intravenous
- Duration of treatment / exposure:
- Dosages of 0, 1 , 2, 4 gr I/kg were administered intravenously to the female as a single dose every other day beginning 14 days prior to mating, daily on gestation days 0 through 6 andon alternate days thereafter, until weaning of the pups at lactation day 21.
- Frequency of treatment:
- Dosages of 0, 1 , 2, 4 gr I/kg were administered intravenously to the female as a single dose every other day beginning 14 days prior to mating, daily on gestation days 0 through 6 andon alternate days thereafter, until weaning of the pups at lactation day 21.
Doses / concentrations
- Remarks:
- Doses / Concentrations:0, 1 , 2, 4 gr I/kgBasis:
- No. of animals per sex per dose:
- Groups of 15 males and 30 females were used. Dosages of 0, 1 , 2, 4 gr I/kg were administered intravenously to the female as a single dose every other day beginning 14 days prior to mating, daily on gestation days 0 through 6 andon alternate days thereafter, until weaning of the pups at lactation day 21.
- Control animals:
- yes
Results and discussion
Results: P0 (first parental generation)
Effect levels (P0)
- Dose descriptor:
- dose level: 4
- Remarks:
- gI/kg
- Effect level:
- ca. 10.8 other: mL/kg
- Sex:
- male/female
- Basis for effect level:
- other: No NOAEC or NOAEL identified
- Remarks on result:
- not measured/tested
- Remarks:
- Effect level not specifiedGeneration not specified (migrated information)
Results: F1 generation
Effect levels (F1)
- Dose descriptor:
- other: 0
- Remarks:
- No record
- Generation:
- F1
- Effect level:
- 0 other: No record
- Based on:
- not specified
- Sex:
- not specified
- Basis for effect level:
- other: No record
- Remarks on result:
- not measured/tested
Overall reproductive toxicity
- Reproductive effects observed:
- not specified
Any other information on results incl. tables
The fertility index in this study was extremely low, although there was no evidence to suggest that the reduced fertility was treatment-related. There was no evidence of maternal toxicity in the F0 generation and the mean uterine examination values, pup survival indices and mean pup body weights in all treated groups were comparable to the controls. There was no effect on F0 female estrus cycle, fertility, parturition or mean gestation length. Treatment of the F0 female rats did not effect the appearance, behavious, litter size, number of stillborn pups, bodyweight at birth or survival of the F1 generation.
Applicant's summary and conclusion
- Conclusions:
- No treatment related findings were observed on F0 females or pups.
- Executive summary:
This study was conducted in Spraque-Dawley rats. Groups of 15 males and 30 females were used. Dosages of 0, 1 , 2, 4 gr I/kg were administered intravenously to the female as a single dose every other day beginning 14 days prior to mating, daily on gestation days 0 through 6 andon alternate days thereafter, until weaning of the pups at lactation day 21. The concentration of iodine adminiestered was 370 mg I/ml. The control group received physiological saline. The males were not treated. 10 females per group were killed on day 13 and the remaining females allowed to deliver. The fertility index in this study was extremely low, although there was no evidence to suggest that the reduced fertility was treatment-related. There was no evidence of maternal toxicity in the F0 generation and the mean uterine examination values, pup survival indices and mean pup body weights in all treated groups were comparable to the controls. There was no effect on F0 female estrus cycle, fertility, parturition or mean gestation length. Treatment of the F0 female rats did not effect the appearance, behavious, litter size, number of stillborn pups, bodyweight at birth or survival of the F1 generation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.